Cardiff Oncology (CRDF) Selling, General & Administrative (2011 - 2026)
Cardiff Oncology (CRDF) recorded Selling, General & Administrative of $3.8 million in Q2 2026, up 14.6% from $3.32 million a year earlier.
Cardiff Oncology (CRDF) Selling, General & Administrative (2011 - 2026) Analysis & Trends
On a TTM basis, Cardiff Oncology's Selling, General & Administrative came in at $14.01 million as of Jun 30, 2026, up 4.0% year-over-year; for FY2025, it was $14.22 million, up 14.0% from FY2024.
- Annual Selling, General & Administrative has a five-year compound annual growth rate of 11.6% (FY2020 to FY2025).
- Across earlier years, Selling, General & Administrative came in at $12.48 million in FY2024 (-4.3%), $13.04 million in FY2023 (-1.0%), $13.18 million in FY2022 (+11.3%) and $11.84 million in FY2021 (+44.1%).
- Quarterly Selling, General & Administrative has ranged from $2.73 million in Q4 2023 to $4.3 million in Q2 2023 over the past five years.
- On a year-over-year basis, Selling, General & Administrative rose in six of the last seven quarters, with growth averaging 12.4%.
- Peak year-over-year performance for Selling, General & Administrative in the last five years was growth of 78.2% in Q3 2021, against a decline of 25.2% in Q2 2024 at the low end.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 6.29 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 3.24 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 5.65 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Cardiff Oncology | 62.34 Mn | 27.84 Mn | - | 3.80 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.80 Mn |
| Dec 31, 2025 | 3.00 Mn |
| Sep 30, 2025 | 3.90 Mn |
| Jun 30, 2025 | 3.32 Mn |
| Mar 31, 2025 | 4.01 Mn |
| Dec 31, 2024 | 3.01 Mn |
| Sep 30, 2024 | 3.13 Mn |
| Jun 30, 2024 | 3.22 Mn |
| Mar 31, 2024 | 3.13 Mn |
| Dec 31, 2023 | 2.73 Mn |
| Sep 30, 2023 | 2.94 Mn |
| Jun 30, 2023 | 4.30 Mn |
| Mar 31, 2023 | 3.08 Mn |
| Dec 31, 2022 | 3.08 Mn |
| Sep 30, 2022 | 3.08 Mn |
| Jun 30, 2022 | 3.09 Mn |
| Mar 31, 2022 | 3.94 Mn |
| Dec 31, 2021 | 3.84 Mn |
| Sep 30, 2021 | 2.93 Mn |
| Jun 30, 2021 | 2.84 Mn |
Cardiff Oncology Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=CRDF&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "CRDF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=CRDF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();